XpediteMD updates and content

Join XpediteMD this fall at two oncology conferences in San Francisco and Chicago to see our AI-powered Cancer Navigation Platform in action.

“Time Is Money”: Why Eliminating Cancer Treatment Delays Is a Business Imperative for Health Insurers & Cancer Providers

Cancer patient navigation is no longer just essential—it’s billable.

New Study Co-Authored by XpediteMD CEO Reveals Urgent Risks of Delays in Breast Cancer Surgery

XpediteMD showcased its groundbreaking Patient Navigation Billing tools at ASBrS 2025 in Las Vegas, with leadership-led demos and a spotlight symposium at the Bellagio.

CoC National Cancer Database announces a new breast quality measure that establishes “time to therapeutic breast surgery <60 days”

Applying the “golden hour” to cancer care can improve survival by ensuring timely, high-quality treatment through clinical pathways and digital tools.

“Reducing Delays of Breast Cancer Care Using an Innovative Digital Health Platform” - published in the American Journal of Accountable Care

Being named a finalist in the CancerX Moonshot Accelerator Contest is a major milestone for XpediteMD

SilverSummit Healthplan sends out a press release lauding how XpediteMD is helping its breast cancer patients obtain breast cancer care much faster.

XpediteMD covered in news story in Journal of Clinical Pathways about XpediteMD’s innovative solution to the time to treatment problem.